Non-dilutive funding refers to financing that does not require selling or giving away equity to raise capital. Therefore, it does not result in the dilution of the existing company owners. Examples include commercial loans, profit-sharing arrangements, foundation grants, and government SBIR & STTR grants. This meeting will focus primarily on the latter type of non-dilutive...
Biocom California and NIRI San Diego invite you to join us on Tuesday, August 3rd for an in-person event geared towards CFOs and Investor Relations professionals within the life science industry, as we welcome back Chief Economist of Nasdaq, Inc., Phil Mackintosh. Phil's team is responsible for a variety of research and analysis to improve...
It wasn’t long ago when we first heard about the promise of stem cells. They were the wave of the future. With stem cells we’d be able to cure disease, repair organs and test new drugs for effectiveness before introducing them into humans. Has the promise of stem cells been overstated? No. The promise has...
MD&M West brings together medtech engineers, business leaders, disruptive companies, and innovative thinkers to create powerful solutions and life-changing medical devices.
Please join us for Basics of Biotech March August 10-13, 2021, from 9:00 am to 1:00 pm daily. This interactive, four-day virtual course covers the process of a drug from discovery to commercialization, including regulatory filings and manufacturing. Location: Virtually
Join other SF Bay biotech professionals for a free virtual tour As a biotech professional in the San Francisco Bay area, you're invited to a free virtual tour of Explora BioLabs' newest OnDemand vivarium location in Alameda. Biotech experts and researchers know Explora BioLabs as the nation's largest provider of preclinical, Ph.D.-backed contract vivarium facilities and services—what...
The last few years has seen major advancements in cancer treatment through immunotherapy. This symposium aims to provide a comprehensive overview of the emerging concepts in cancer immunotherapy from the latest biologic insights in academia and the latest clinical data for approved and investigational immuno-oncology agents from key biotech and pharmaceutical companies. We will discuss...
Biocom California invites you to join us for a virtual webinar on August 12th, as we hear about the bold moves that our emerging San Diego biotech companies are making. The need for innovation is only ramping up and these San Diego based companies prove to be a driving force in the life science community....
Learn about startup, scaleup and growth at leading biotech companies, with panelists Ana Hooker of Exact Sciences, Tom Foti of Aldevron, Carter Cliff of Vascugen, and Cathy Rasmussen of the Forward BIO Institute. These industry leaders, startup veterans and founders can speak to companies at all stages, including how they leveraged UW–Madison affiliated UW–Madison-affiliated resources...
Your skills at using integrated TMF technology will make or break the success of your clinical research. A full command of the details is essential – yet the dangers and variables change significantly based on your company’s size and worldwide markets. DGE’s 2nd eTMF Forum provides unprecedented depth on meeting regulatory requirements, prepping for audits,...
Deep learning for healthcare management. Software modeling of drug activity in the body. Machine learning-based diagnostics. Increasingly, biotech and healthtech startups are solving problems and building solutions through advanced computing technology and artificial intelligence. Hear from some of the region’s most innovative startups working in the intersection of biotech and computing—AIQ Solutions, PROMISS Diagnostics, and...
Join us for a lively discussion as we hear from some of the pharma industry’s leading temperature control experts. Hear the unique production, storage and logistics challenges they each battled during the unprecedented pandemic. They will share the valuable lessons they learned and their outlook on the future of temperature controlled logistics, risk mitigation and...
